Search Results - "Gewirtz, David A"

Refine Results
  1. 1

    The Four Faces of Autophagy: Implications for Cancer Therapy by GEWIRTZ, David A

    Published in Cancer research (Chicago, Ill.) (01-02-2014)
    “…It is generally thought that autophagy has two primary and opposing functions in tumor cells in response to stress induced by chemotherapy or radiation. One is…”
    Get full text
    Journal Article
  2. 2

    Tumor Cell Escape from Therapy-Induced Senescence as a Model of Disease Recurrence after Dormancy by Saleh, Tareq, Tyutyunyk-Massey, Liliya, Gewirtz, David A

    Published in Cancer research (Chicago, Ill.) (15-03-2019)
    “…Senescence, a durable form of growth arrest, represents a primary response to numerous anticancer therapies. Although the paradigm that senescence is…”
    Get full text
    Journal Article
  3. 3

    The Challenge of Developing Autophagy Inhibition as a Therapeutic Strategy by Gewirtz, David A

    Published in Cancer research (Chicago, Ill.) (01-10-2016)
    “…The finding that cancer chemotherapeutic drugs and ionizing radiation often promote autophagy has provided the foundation for clinical trials combining…”
    Get full text
    Journal Article
  4. 4

    Triangular Relationship between p53, Autophagy, and Chemotherapy Resistance by Xu, Jingwen, Patel, Nipa H, Gewirtz, David A

    “…Chemotherapy and radiation often induce a number of cellular responses, such as apoptosis, autophagy, and senescence. One of the major regulators of these…”
    Get full text
    Journal Article
  5. 5

    Is Autophagy Always a Barrier to Cisplatin Therapy? by Xu, Jingwen, Gewirtz, David A

    Published in Biomolecules (Basel, Switzerland) (17-03-2022)
    “…Cisplatin has long been a first-line chemotherapeutic agent in the treatment of cancer, largely for solid tumors. During the course of the past two decades,…”
    Get full text
    Journal Article
  6. 6

    Cytoprotective and nonprotective autophagy in cancer therapy by Gewirtz, David A.

    Published in Autophagy (29-09-2013)
    “…Two primary forms of autophagy have been identified in the field of cancer therapy based on their apparent functions in the tumor cell; these are the…”
    Get full text
    Journal Article
  7. 7

    Therapy-Induced Senescence: An "Old" Friend Becomes the Enemy by Saleh, Tareq, Bloukh, Sarah, Carpenter, Valerie J, Alwohoush, Enas, Bakeer, Jomana, Darwish, Sarah, Azab, Belal, Gewirtz, David A

    Published in Cancers (29-03-2020)
    “…For the past two decades, cellular senescence has been recognized as a central component of the tumor cell response to chemotherapy and radiation…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Is Senescence Reversible? by Chakradeo, Shweta, Elmore, Lynne W, Gewirtz, David A

    Published in Current drug targets (01-03-2016)
    “…Senescence was originally identified by the finite lifespan of normal cells that is a consequence of telomere shortening with each cycle of DNA replication…”
    Get more information
    Journal Article
  10. 10

    Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors by Elshazly, Ahmed M, Gewirtz, David A

    “…The bromodomain and extra-terminal domain (BET) family inhibitors are small molecules that target the dysregulated epigenetic readers, BRD2, BRD3, BRD4 and…”
    Get full text
    Journal Article
  11. 11

    Autophagy, senescence and tumor dormancy in cancer therapy by Gewirtz, David A.

    Published in Autophagy (16-11-2009)
    “…The relationships between autophagy and apoptosis have been examined quite extensively and have often been shown to be reciprocally regulated responses to…”
    Get full text
    Journal Article
  12. 12

    The Cytoprotective Role of Autophagy in Response to BRAF-Targeted Therapies by Elshazly, Ahmed M, Gewirtz, David A

    “…BRAF-targeted therapies are widely used for the treatment of melanoma patients with BRAF V600 mutations. Vemurafenib, dabrafenib as well as encorafenib have…”
    Get full text
    Journal Article
  13. 13

    The Switch between Protective and Nonprotective Autophagy; Implications for Autophagy Inhibition as a Therapeutic Strategy in Cancer by Gewirtz, David A

    Published in Biology (Basel, Switzerland) (04-01-2020)
    “…Autophagy, a process of cellular self-degradation and cell survival whereby the cell generates energy and metabolic intermediates under conditions of stress…”
    Get full text
    Journal Article
  14. 14

    The Roles of Autophagy and Senescence in the Tumor Cell Response to Radiation by Patel, Nipa H., Sohal, Sahib S., Manjili, Masoud H, Harrell, J. Chuck, Gewirtz, David A.

    Published in Radiation research (01-08-2020)
    “…Radiation is a critical pillar in cancer therapeutics, exerting its anti-tumor DNA-damaging effects through various direct and indirect mechanisms. Radiation…”
    Get full text
    Journal Article
  15. 15

    Cytotoxic autophagy in cancer therapy by Sharma, Khushboo, Le, Ngoc, Alotaibi, Moureq, Gewirtz, David A

    “…Autophagy is a process of cellular self-digestion, whereby the cell degrades subcellular materials in order to generate energy and metabolic precursors in…”
    Get full text
    Journal Article
  16. 16

    Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐XL–BAX interaction by Saleh, Tareq, Carpenter, Valerie J., Tyutyunyk‐Massey, Liliya, Murray, Graeme, Leverson, Joel D., Souers, Andrew J., Alotaibi, Moureq R., Faber, Anthony C., Reed, Jason, Harada, Hisashi, Gewirtz, David A.

    Published in Molecular oncology (01-10-2020)
    “…Senescent tumor cells can be selectively eliminated by the BH3 mimetic, ABT‐263 (navitoclax), via senolysis. We show that ABT‐263 inhibits the interaction…”
    Get full text
    Journal Article
  17. 17

    Effects of paclitaxel on the development of neuropathy and affective behaviors in the mouse by Toma, Wisam, Kyte, S. Lauren, Bagdas, Deniz, Alkhlaif, Yasmin, Alsharari, Shakir D., Lichtman, Aron H., Chen, Zhi-Jian, Del Fabbro, Egidio, Bigbee, John W., Gewirtz, David A., Damaj, M. Imad

    Published in Neuropharmacology (01-05-2017)
    “…Paclitaxel, one of the most commonly used cancer chemotherapeutic drugs, effectively extends the progression-free survival of breast, lung, and ovarian cancer…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Young plasma reverses age‐dependent alterations in hepatic function through the restoration of autophagy by Liu, Anding, Guo, Enshuang, Yang, Jiankun, Yang, Yan, Liu, Shenpei, Jiang, Xiaojing, Hu, Qi, Dirsch, Olaf, Dahmen, Uta, Zhang, Cuntai, Gewirtz, David A, Fang, Haoshu

    Published in Aging cell (01-02-2018)
    “…Summary Recent studies showing the therapeutic effect of young blood on aging‐associated deterioration of organs point to young blood as the solution for…”
    Get full text
    Journal Article
  20. 20